About Gilead

Gilead Sciences develops transformative medicines for people facing life-threatening diseases. With a portfolio spanning virology, oncology and inflammation, the company brings over three decades of scientific rigour to breakthrough therapies that change outcomes for patients worldwide. Operating across 35 countries, Gilead combines research excellence with a commitment to health equity. Beyond discovering medicines, Gilead addresses barriers to care through licensing programmes, local partnerships and philanthropic initiatives that expand treatment access and support public health infrastructure in underserved regions. Every therapy represents scientific progress and a step towards a healthier, more equitable world.